Growth and the Developing Brain in 1q21.1 Microdeletion

While a 1q21.1 microdeletion can affect many parts of the body, its most common impacts are on how the brain and body grow and develop. Because this missing piece of genetic material contains instructions vital for neurological function, many children face challenges with motor skills, speech, and learning ^[1][2].

It is important to remember that these symptoms are part of a broad spectrum, and the percentages below come from selected clinical groups (families who sought medical care because of symptoms). They do not predict an individual child’s course. Some individuals may have significant needs, while others—including parents who only discover they have the deletion after their child is diagnosed—may have lived their entire lives with few or no noticeable symptoms ^[1][3].

Early Growth and Development

For many families, the first signs of the syndrome appear in infancy or early childhood. These often involve growth and the achievement of typical milestones.

• Growth and Feeding: In some clinical groups, up to 68% of children experience poor weight gain or growth faltering (sometimes medically termed “failure to thrive”) ^[2]. This can sometimes be linked to feeding difficulties or hypotonia (low muscle tone), which can make sucking and swallowing more tiring for a baby ^[4]. If your child coughs with meals or struggles to gain weight, following their growth curve closely and involving a feeding specialist or dietitian is highly practical.
• Microcephaly: About 51% to 60% of children with the distal deletion in clinical cohorts have a head size that is smaller than average for their age and sex ^[2][5]. While this is a common feature of the syndrome, it does not by itself predict a child’s intellectual ability.
• Developmental Delays: Approximately 74% of children with this deletion in these cohorts experience some form of developmental delay ^[2]. This typically includes:
  • Motor Skills: Delays in sitting up, crawling, or walking, often complicated by low muscle tone (hypotonia) or coordination issues ^[4][2].
  • Speech and Language: Many children are slower to begin speaking or have articulation abnormalities, making their speech difficult for others to understand at first ^[4]. Note: Always ask for a formal hearing evaluation (audiology), as treatable hearing loss can easily be mistaken for a developmental speech delay.

Neurological Health and Seizures

The missing genetic material can also affect the brain’s electrical activity. Roughly 30% of individuals in clinical studies have been reported to experience seizures ^[2].

Seizures in 1q21.1 can look very different from the generalized tonic-clonic seizures (formerly called “grand mal”) often seen in movies. They may appear as:

• Absence Seizures: Brief periods of staring into space or “blanking out.”
• Atonic Seizures: Sudden “drop attacks” where a child momentarily loses muscle control and falls.
• Rhythmic Jerking: Subtle, repetitive movements of the limbs.

Because seizures can sometimes be subtle, any new or unusual “staring spells” or sudden changes in awareness should be documented. A genetic diagnosis alone does not automatically mean that a routine EEG is useful; the decision is symptom-driven. If you notice unusual staring spells or sudden falls, try to record a safe video of the event to show your neurologist, as staring has many non-seizure causes.

Understanding Psychiatric Risks

As children with a 1q21.1 microdeletion grow into adolescence and adulthood, the focus of care often shifts toward mental health. It is vital to frame these risks as probabilities, not certainties. Most people with this deletion do not develop severe psychiatric conditions ^[1].

Schizophrenia

The 1q21.1 distal microdeletion is a known risk factor for schizophrenia, a condition that affects how a person thinks, feels, and behaves. Research indicates that the deletion is associated with roughly an eight-fold relative increase in risk compared to the general population ^[6]. To put this in absolute context: if the general population risk is around 1%, an eight-fold increase means the risk is elevated, but the vast majority of carriers will never develop the disorder ^[6].

Mood and Behavioral Health

Other mental health considerations are more common than schizophrenia:

• Depression and Bipolar Disorder: Some studies suggest an increased risk for major depressive disorder and, particularly in men, an association with bipolar disorder ^[7].
• ADHD and Autism: While more common in other genetic syndromes, some children with 1q21.1 deletions show traits of ADHD (attention-deficit/hyperactivity disorder) or Autism Spectrum Disorder (ASD), including challenges with social interaction or impulsive behavior ^[7][8].

Monitoring for the Future

Because these symptoms often do not appear until later in life, long-term follow-up is essential ^[1]. Monitoring does not require a mandatory annual trip to a specialist psychiatrist for every child. Instead, your primary care doctor can conduct age-appropriate mental health screenings. Early identification of mood changes or social withdrawal allows for faster access to therapy and support, which can significantly improve long-term outcomes ^[1][4].